A Phase I/II Trial Investigating LOAd703 in Combination With Atezolizumab in Malignant Melanoma

Condition:   Malignant Melanoma Interventions:   Genetic: delolimogene mupadenorepvec;   Biological: atezolizumab Sponsors:   Lokon Pharma AB;   Precision Oncology LLC Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials